Tag Archives: BIO Investor Forum

Vote for Your Favorite Innovator – BIF’s Buzz of BIO Voting Now Open!

Buzz of BIO contest, BIO Investor Forum

During the past week nominations were accepted for this year’s Buzz of BIO contest sponsored by the 2016 BIO Investor Forum (BIF)—October 18-19 at the Westin St. Francis Hotel in San Francisco. Ten innovative biotech companies were nominated in each of two categories—Early Stage Entrepreneurs and Late Stage Leaders. Now it’s time to vote. Cast your ballot for a company in each category. Winners will receive complimentary conference registration, a Company Presentation and promotion to industry leaders including Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Win a Free Company Presentation at the 2016 BIO Investor Forum

Buzz of BIO contest, BIO Investor Forum

Nominations are now open for the Buzz of BIO contest at the 2016 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Early-stage companies looking for their next financing round or late-stage companies hoping to make the valuable connections needed to take Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Plan Now to Attend the 15th Annual BIO Investor Forum Oct 18-19, San Francisco

BIO Investor Forum

The BIO Investor Forum, now in its 15th year, is open for registration. An international conference with plenary sessions, business roundtables, company presentations, therapeutic workshops, networking opportunities and partnering meetings, it is designed to help early-stage companies find sources of capital. Attendees will have opportunities to learn about the latest investment trends as well as showcase their company to qualified investors. BIO is pleased to announce that Rachel Haurwitz, PhD, CEO of Caribou Biosciences, will Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Haves and Have Nots in Biotech Venture Capital

US_VC_Funding_2009_2014

Recent data from the BIO Industry Analysis team tells a story of “haves and have-nots” in US biopharma venture capital. Three key findings were discussed Wednesday at the 14th Annual BIO Investor Forum. The first finding from the recent study is that funding of therapeutic companies is strong for late rounds (Series B and above), but weak for Series A. Although total levels of venture funding have been climbing recently, the majority of the increase is from late rounds. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Fireside Chat: “Everything we knew in science 10 years ago is wrong.”

admin-ajax.php-2

The speed of scientific innovation these days is comparable to the PC innovation era of the 1980s, according to Robert Nelsen of ARCH Venture Partners at today’s BIO Investor Forum fireside chat. This is not to say that he feels investing in biopharma is a short term game. Robert urged the audience to “keep their faith” in good science and the “good ideas will percolate up” to yield innovative breakthroughs. Having played a significant role Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,